| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Bosutinib (SKI-606) |
|---|
| Description | Bosutinib (SKI-606) is a novel tyrosine kinase inhibitor. Bosutinib can overcome not only Bcr-Abl-dependent mechanisms of resistance, but also those that are Bcr-Abl-independent. It is used to treat patients with chronic myelogenous leukemia (CML) who demonstrate resistance to Imatinib or develop resistance during treatment. MW: 530.45. Purity ≥99% by HPLC |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | SKI-607 |
|---|
| Gene, Accession, CAS # | CAS: 380843-75-4 |
|---|
| Catalog # | 1584-5 |
|---|
| Price | |
|---|
| Order / More Info | Bosutinib (SKI-606) from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|